SCHEMBL8640475

SCHEMBL8640475

Cc1ccc2c(c1)c(C1CCN(CCN3CCN(C(C)C)C3=O)CC1)cn2-c1ccc(F)cc1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLNR O43193 1/20 0.57
CACNA1F O60840 1/20 0.57
NR1I2 O75469 1/20 0.57
ABCB11 O95342 1/20 0.57
ABCB1 P08183 1/20 0.57
ADRB1 P08588 1/20 0.57
HTR1A P08908 1/20 0.57
ADRA2A P08913 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
CHRM1 P11229 1/20 0.57
DRD2 P14416 1/20 0.57
ADRA2B P18089 1/20 0.57
ADRA2C P18825 1/20 0.57
CHRM3 P20309 1/20 0.57
MAOA P21397 1/20 0.57
CNR1 P21554 1/20 0.57
DRD1 P21728 1/20 0.57
DRD4 P21917 1/20 0.57
KCNA5 P22460 1/20 0.57
SLC6A2 P23975 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8638021 0.94 MLNR (0.59) MLNRCACNA1FNR1I2ABCB11ABCB1
SCHEMBL9147354 0.93
SCHEMBL7380855 0.91 MLNR (0.70) MLNRCACNA1FNR1I2ABCB11ABCB1
SCHEMBL8640368 0.90 MLNR (0.55) MLNRCACNA1FNR1I2ABCB11ABCB1
SCHEMBL8638345 0.89 KCNH2 (0.68) KCNH2
SCHEMBL9146733 0.88 MLNR (0.57) MLNRCACNA1FNR1I2ABCB11ABCB1
SCHEMBL9150368 0.85
SCHEMBL9153067 0.85
SCHEMBL9151105 0.85 MLNR (0.61) MLNRCACNA1FNR1I2ABCB11ABCB1
SCHEMBL9150260 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575430-B1 PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ADDICTION TO DRUGS AND SUBSTANCES OF ABUSE LUNDBECK & CO AS H (DK) 1998-08-05 EP disclosed
EP-0575429-B1 TREATMENT OF COGNITIVE DISORDERS LUNDBECK & CO AS H (DK) 1995-12-06 EP disclosed
US-5462948-A Treatment of addiction to drugs and substances of abuse H. LUNDBECK A/S (DK) 1995-10-31 US disclosed
US-5444073-A Administering 1-aryl-3-(4-piperidyl)-indole derivatives H. LUNDBECK A/S (DK) 1995-08-22 US disclosed
US-5439922-A Administering dopamine antagonists having reduced side effects H. LUNDBECK A/S (DK) 1995-08-08 US disclosed
EP-0533824-B1 PIPERIDYL-SUBSTITUTED INDOLES LUNDBECK & CO AS H (DK) 1994-11-09 EP disclosed